REFERENCE
Angus DC, Clermont G, Linde-Zwirble WT, Musthafa AA, Dremsizov TT, Lidicker J, Lave JR, NO-06 Investigators.Healthcare costs and long-term outcomes after acute respiratory distress syndrome: a phase III trial of inhaled nitric oxide. Critical Care Medicine 34: 2883-2890, No. 12, Dec 2006
Rights and permissions
About this article
Cite this article
Nitric oxide no more worthwhile than placebo in ARDS. Pharmacoecon. Outcomes News 521, 8 (2007). https://doi.org/10.2165/00151234-200705210-00025
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705210-00025